Skip to main content
OpenTrials

Clinical trial condition

FGF19 Gene Overexpression

Explore clinical trials studying FGF19 Gene Overexpression. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

FGF19 Gene Overexpression trial results

Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

NCT06915753

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +26 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center at Mount Zion San Francisco, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • The University of Kansas Medical Center Westwood, Kansas, United States
View all 16 locations
View Trial Details

Related conditions